Glucagon-like peptide-1

Glucagon-like Peptide-1 (GLP-1)

File:Principals funcions GLP-1.png

Principals funcions GLP-1

Glucagon-like peptide-1 (GLP-1) is a hormone that is secreted from the intestines in response to food intake. It plays a crucial role in the regulation of blood glucose levels and has been implicated in the pathophysiology of type 2 diabetes.

Glucagon-like Peptide-1 (GLP-1) is an incretin hormone that plays a critical role in glucose metabolism, insulin secretion, and appetite regulation. Produced in the intestinal L cells and certain neurons within the brain, GLP-1 is a key player in the enteroinsular axis, mediating the increase in insulin secretion in response to nutrient intake. This article delves into the physiological functions of GLP-1, its therapeutic applications, particularly in the treatment of type 2 diabetes mellitus and obesity, and highlights recent research in the field.

Physiological Role

GLP-1 exerts multiple actions on glucose homeostasis and gastrointestinal function:

• Insulin Secretion: Enhances insulin secretion from pancreatic β-cells in a glucose-dependent manner, preventing hyperglycemic spikes post-meal.
• Gastric Emptying: Slows gastric emptying, aiding in the reduction of postprandial glucose levels.
• Appetite Regulation: Acts on the brain to promote satiety and reduce food intake, contributing to weight management.
• Glucagon Suppression: Inhibits glucagon secretion, thereby reducing hepatic glucose production.

File:MMDB ID 62600 PDB ID 3C59 Crystal Structure Of The Ligand-Bound Glucagon-Like Peptide- 1 Receptor Extracellular Domain.png

Illustration of insulin and glucagon regulation in glucose metabolism.

Therapeutic Uses

GLP-1's role in enhancing insulin secretion and promoting satiety has led to the development of GLP-1 receptor agonists for managing type 2 diabetes and obesity:

• Type 2 Diabetes Mellitus: GLP-1 receptor agonists, such as exenatide and liraglutide, improve glycemic control by enhancing insulin secretion and suppressing glucagon release.
• Obesity: These agents reduce appetite and food intake, leading to significant weight loss in patients with obesity.

GLP-1 Receptor Agonists

GLP-1 receptor agonists mimic the action of endogenous GLP-1, offering several benefits:

• Improved glycemic control with a low risk of hypoglycemia
• Weight reduction
• Potential cardiovascular benefits

Function

GLP-1 is secreted by L cells in the intestine in response to food intake. It acts on the pancreas to stimulate insulin secretion and inhibit glucagon secretion, thereby helping to regulate blood glucose levels. GLP-1 also slows gastric emptying and promotes satiety, which can help to control body weight.

Role in disease

Impaired GLP-1 secretion and action have been implicated in the pathophysiology of type 2 diabetes. GLP-1-based therapies, such as GLP-1 receptor agonists and DPP-4 inhibitors, are currently used in the treatment of this disease.

Therapeutic use

GLP-1-based therapies are used in the treatment of type 2 diabetes. These include GLP-1 receptor agonists, which mimic the action of GLP-1, and DPP-4 inhibitors, which prevent the breakdown of GLP-1. These therapies can help to improve blood glucose control and promote weight loss.

See also

• Insulin
• Glucagon
• Type 2 diabetes
• GLP-1 receptor agonists
• DPP-4 inhibitors

References

Ad. Transform your life with W8MD's

GLP-1 weight loss injections special from $29.99

W8MD weight loss doctors team

W8MD Medical Weight Loss, Sleep and Medspa offers physician-supervised medical weight loss programs: NYC medical weight loss Philadelphia medical weight loss

Affordable GLP-1 Weight Loss Shots

Budget GLP-1 injections NYC (insurance & self-pay options) Popular treatments:

• • Semaglutide starting from $29.99/week
  • Tirzepatide starting from $45.00/week

✔ Most insurances accepted for visits ✔ Prior authorization support when eligible

Start your physician weight loss NYC journey today:

📍 NYC: Brooklyn weight loss center 📍 Philadelphia: Philadelphia weight loss center

📞 Call: 718-946-5500 (NYC) | 215-676-2334 (Philadelphia)

Tags: Affordable GLP1 weight loss NYC, Wegovy NYC, Zepbound NYC, Philadelphia medical weight loss